{
  "id": "56cae51f5795f9a73e000025",
  "type": "yesno",
  "question": "Are immune cells affected in Amyotrophic Lateral Sclerosis?",
  "ideal_answer": "In ALS T-cell deficiency increases neuronal loss, while boosting T cell levels reduces it.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/17852013",
    "http://www.ncbi.nlm.nih.gov/pubmed/7595631",
    "http://www.ncbi.nlm.nih.gov/pubmed/23881705",
    "http://www.ncbi.nlm.nih.gov/pubmed/21829620",
    "http://www.ncbi.nlm.nih.gov/pubmed/25199710",
    "http://www.ncbi.nlm.nih.gov/pubmed/7551976",
    "http://www.ncbi.nlm.nih.gov/pubmed/25904790",
    "http://www.ncbi.nlm.nih.gov/pubmed/20406178",
    "http://www.ncbi.nlm.nih.gov/pubmed/24995608"
  ],
  "snippets": [
    {
      "text": "Therapeutic immunization of mSOD1 mice with a myelin-derived peptide led to CP activation, and was followed by the accumulation of immunoregulatory cells, including IL-10-producing monocyte-derived macrophages and Foxp3(+) regulatory T cells, and elevation of the neurotrophic factors IGF-1 and GDNF in the diseased spinal cord parenchyma",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25904790",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25904790",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Amyotrophic lateral sclerosis (ALS) is a rapidly progressing fatal neurodegenerative disorder characterized by the selective death of motor neurons (MN) in the spinal cord, and is associated with local neuroinflammation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21829620",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "T-cell deficiency increases neuronal loss, while boosting T cell levels reduces it.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21829620",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "As disease accelerates, a shift occurs from beneficial immune responses (involving M2 microglia and regulatory T-cells) to deleterious immune responses (involving M1 microglia and Th1 cells). In this review, we underscore the importance of immune-mediated mechanisms in the pathogenesis of ALS and discuss the alterations and distinct phenotypes of immune cells at the different stages of disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23881705",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Immunological disturbances have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Chemokines are involved in the recruitment of immune cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17852013",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The immune system has been found to be involved with positive and negative effects in the nervous system of amyotrophic lateral sclerosis (ALS) patients. In general, T cells, B cells, NK cells, mast cells, macrophages, dendritic cells, microglia, antibodies, complement and cytokines participate in limiting damage.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20406178",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Immunological disturbances have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Chemokines are involved in the recruitment of immune cells.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17852013",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "We propose the following mechanism for the effect of mesenchymal stem cells (MSCs) administered intrathecally in amyotrophic lateral sclerosis (ALS): MSCs increase infiltration of peripheral immune cells into CNS and skew the infiltrated immune cells toward regulatory T lymphocytes (Treg ) and Th2 lymphocytes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24995608",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Immune cell infiltration to the brain&apos;s territory was considered for decades to reflect a pathological process in which immune cells attack the central nervous system (CNS); such a process is observed in the inflammatory autoimmune disease, multiple sclerosis (MS).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25199710",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000690",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012598",
    "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002477",
    "http://www.disease-ontology.org/api/metadata/DOID:230"
  ],
  "exact_answer": "Yes"
}